Incyte Corp. [INCY] stock is trading at $68.06, up 2.97%. An important factor to consider is whether the stock is rising or falling in short-term value. The INCY shares have gain 6.84% over the last week, with a monthly amount glided 3.66%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Incyte Corp. [NASDAQ: INCY] stock has seen the most recent analyst activity on October 01, 2024, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $84. Previously, Truist downgraded its rating to Hold on September 18, 2024, and dropped its price target to $74. On July 02, 2024, downgrade downgraded it’s rating to Underperform and revised its price target to $48 on the stock. Deutsche Bank started tracking the stock assigning a Hold rating and suggested a price target of $55 on May 23, 2024. Cantor Fitzgerald initiated its recommendation with a Neutral. Jefferies started tracking with a Buy rating for this stock on February 23, 2024, and assigned it a price target of $81. In a note dated February 14, 2024, JMP Securities downgraded an Mkt Perform rating on this stock.
Incyte Corp. [INCY] stock has fluctuated between $50.27 and $70.36 over the past year. Currently, Wall Street analysts expect the stock to reach $75.63 within the next 12 months. Incyte Corp. [NASDAQ: INCY] shares were valued at $68.06 at the most recent close of the market. An investor can expect a potential return of 11.12% based on the average INCY price forecast.
Analyzing the INCY fundamentals
Incyte Corp. [NASDAQ:INCY] reported sales of 3.86B for the trailing twelve months, which represents a growth of 9.34%. Gross Profit Margin for this corporation currently stands at 0.93% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at 0.09%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.02 and Total Capital is 0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 66.64 points at the first support level, and at 65.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 68.82, and for the 2nd resistance point, it is at 69.59.
Ratios To Look Out For
For context, Incyte Corp.’s Current Ratio is 1.92. On the other hand, the Quick Ratio is 1.84, and the Cash Ratio is 0.74. Considering the valuation of this stock, the price to sales ratio is 3.40, the price to book ratio is 4.35 and price to earnings (TTM) ratio is 191.77.
Transactions by insiders
Recent insider trading involved Tray Thomas, Principal Accounting Officer, that happened on Sep 12 ’24 when 572.0 shares were sold. Principal Accounting Officer, Tray Thomas completed a deal on Sep 13 ’24 to sell 382.0 shares. Meanwhile, EVP, General Manager, Europe Dickinson Jonathan Elliott sold 8450.0 shares on Sep 12 ’24.
